Genomic Profiling is Incorporated in the New AJCC Staging System

NCCN2017 has 35 videos Subscribe Here

Description: Stephen B. Edge, MD of Roswell Park Cancer Institute discusses the importance of personalized medicine, specifically genomic profiling in breast cancer. He states that with more use in genomic profiling, chemotherapy has decreased in need. This was recorded at the 2017 National Comprehensive Cancer Network (NCCN) Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ in Orlando, Florida.
Shared By : NCCN2017
Posted on : 03/31/17
Added : 2 years ago
Category : General